Expression of Interleukin-17, Tumor Necrosis Factor-Alpha, and Matrix Metalloproteinase-8 in Patients with Chronic Peri-Implant Mucositis

Darius Gleiznys; Albertas Kriauciunas; Julius Maminskas; Arturas Stumbras; Dalia Giedrimiene; Christine Niekrash; Alvydas Gleiznys; Jurgina Sakalauskiene; Astra Vitkauskiene

doi:10.12659/MSM.932243

26 October 2021: Clinical Research

Expression of Interleukin-17, Tumor Necrosis Factor-Alpha, and Matrix Metalloproteinase-8 in Patients with Chronic Peri-Implant Mucositis

Darius Gleiznys ^1ABCDEFG* , Albertas Kriauciunas ^1BCDE , Julius Maminskas ^1AB , Arturas Stumbras ^2FG , Dalia Giedrimiene ^3CD , Christine Niekrash ^4CDE , Alvydas Gleiznys ^1AD , Jurgina Sakalauskiene ^1ABEF , Astra Vitkauskiene ^5ACDE

DOI: 10.12659/MSM.932243

Med Sci Monit 2021; 27:e932243

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 3 ROC curve of prognosis bacteria Parvimonas micra by using logistic regression method according to optimal cut-off value of TNF-α in peri-implant crevicular fluid of the mucositis patients untreated group.

Back to the Article

Expression of Interleukin-17, Tumor Necrosis Factor-Alpha, and Matrix Metalloproteinase-8 in Patients with Chronic Peri-Implant Mucositis

Your Privacy